Mylan CEO Heather Bresch Breaks Down The Path Pricing EpiPen | Squawk Box | CNBC

Heather Bresch, Mylan CEO breaks down the pricing path of the EpiPen and the company’s plan to expand access to the drug. » Subscribe to CNBC: About CNBC: From ’Wall Street’ to ’Main Street’ to award winning original documentaries and Reality TV series, CNBC has you covered. Experience special sneak peeks of your favorite shows, exclusive video and more. Connect with CNBC News Online Get the latest news: Find CNBC News on Facebook: Follow CNBC News on Twitter: Follow CNBC News on Google : Follow CNBC News on Instagram: Mylan CEO Heather Bresch Breaks Down The Path Pricing EpiPen | Squawk Box | CNBC